EU stocks dropped for the fourth consecutive time within a mere five-day period as the overall outlook for corporate health looked worse following an onslaught of neutral, if not disappointing forecast results. Drug corporations led the said slump after Novo Nordisk A/S dropped by 7.3%, which led to the firm cutting back on its sales outlook for this year. Deutsche Bank AG decreased by 5.2% after its quarterly trading profit data failed to meet market expectations, while Daimler AG fell back by 2.7% after statements from its officials that profit is expected to increase by only a minimum percentage this 2017.
